These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10463379)

  • 1. Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine?
    Dettling M; Cascorbi I; Hellweg R; Deicke U; Weise L; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1999 May; 32(3):110-2. PubMed ID: 10463379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there genetic determinants of olanzapine-induced agranulocytosis?
    Felber W; Naumann R; Schuler U; Fülle M; Reuster T; Garcia K; Heilemann H
    Pharmacopsychiatry; 2000 Sep; 33(5):197-9. PubMed ID: 11071024
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine-induced agranulocytosis: a case report and review of the literature.
    Tolosa-Vilella C; Ruiz-Ripoll A; Mari-Alfonso B; Naval-Sendra E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):411-4. PubMed ID: 11817522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of clozapine-induced granulocytopenia associated with olanzapine.
    Flynn SW; Altman S; MacEwan GW; Black LL; Greenidge LL; Honer WG
    J Clin Psychopharmacol; 1997 Dec; 17(6):494-5. PubMed ID: 9408818
    [No Abstract]   [Full Text] [Related]  

  • 6. Olanzapine: safe during clozapine-induced agranulocytosis.
    Oyewumi LK; Al-Semaan Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):279-81. PubMed ID: 10770478
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine: hematological reactions.
    CMAJ; 1998 Jul; 159(1):81-2, 85-6. PubMed ID: 9679498
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine after clozapine: the rare case of prolongation of granulocytopaenia.
    Lambert T
    Aust N Z J Psychiatry; 1998 Aug; 32(4):591-2. PubMed ID: 9711381
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine prolongation of granulocytopenia after clozapine discontinuation.
    Konakanchi R; Grace JJ; Szarowicz R; Pato MT
    J Clin Psychopharmacol; 2000 Dec; 20(6):703-4. PubMed ID: 11106146
    [No Abstract]   [Full Text] [Related]  

  • 10. Experiences with clozapine and olanzapine.
    Chatterton R
    Aust N Z J Psychiatry; 1998 Jun; 32(3):463. PubMed ID: 9672741
    [No Abstract]   [Full Text] [Related]  

  • 11. Two cases of olanzapine-induced reversible neutropenia.
    Steinwachs A; Grohmann R; Pedrosa F; Rüther E; Schwerdtner I
    Pharmacopsychiatry; 1999 Jul; 32(4):154-6. PubMed ID: 10505486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
    Iverson S; Zahid N; Uetrecht JP
    Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia.
    Stip E; Langlois R; Thuot C; Mancini-Marïe A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):297-300. PubMed ID: 16978752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y; Scholte WF
    Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-induced neutropenia after clozapine-induced neutropenia.
    Benedetti F; Cavallaro R; Smeraldi E
    Lancet; 1999 Aug; 354(9178):567. PubMed ID: 10470706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?
    Verbelen M; Lewis CM
    Pharmacogenomics; 2015; 16(9):915-7. PubMed ID: 26122865
    [No Abstract]   [Full Text] [Related]  

  • 17. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC; Dettling M; Cascorbi I; Mosyagin I; Salisbury BA; Pierz KA; Zou W; Whalen H; Malhotra AK; Lencz T; Gerson SL; Kane JM; Reed CR
    J Clin Psychiatry; 2011 Apr; 72(4):458-63. PubMed ID: 20868635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.
    Dettling M; Schaub RT; Mueller-Oerlinghausen B; Roots I; Cascorbi I
    Pharmacogenetics; 2001 Mar; 11(2):135-41. PubMed ID: 11266078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia.
    Montgomery J
    Gen Hosp Psychiatry; 2006; 28(1):83-5. PubMed ID: 16377373
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine and haloperidol: potential for neutropenia?
    Abdullah N; Voronovitch L; Taylor S; Lippmann S
    Psychosomatics; 2003; 44(1):83-4. PubMed ID: 12515844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.